Prognostic value of positive histological margins in patients with pancreatic head ductal adenocarcinoma and lymph node involvement: an international multicentric study.

Published on Mar 1, 2021in Hpb3.401
· DOI :10.1016/J.HPB.2020.07.008
Gaëtan-Romain Joliat12
Estimated H-index: 12
(UNIL: University of Lausanne),
Pierre Allemann20
Estimated H-index: 20
(UNIL: University of Lausanne)
+ 10 AuthorsMarkus Schäfer40
Estimated H-index: 40
(UNIL: University of Lausanne)
Source
Abstract
Abstract Background Resection margin status and lymph node (LN) involvement are known prognostic factors for patients who undergo pancreatoduodenectomy for pancreatic ductal adenocarcinoma (PDAC). This study aimed to compare overall survival (OS) and disease-free survival (DFS) by resection margin status in patients with PDAC and LN involvement. Methods A retrospective international multicentric study was performed including four Western centers. Multivariable Cox analysis was performed to identify prognostic factors of OS and DFS. Median OS and DFS were calculated using Kaplan–Meier curves and compared using log-rank tests. Results A cohort of 814 PDAC patients with pancreatoduodenectomy were analyzed. A total of 651 patients had LN involvement (80%). On multivariable analysis R1 resection was not an independent factor of worse OS and DFS in patients with LN involvement (HR 1.1, p = 0.565; HR 1.2, p = 0.174). Only tumor size, grade, and adjuvant chemotherapy were associated with OS and DFS. Median OS and DFS were similar between patients with R0 and R1 resections (23 vs. 20 months, p = 0.196; 15 vs. 14 months, p = 0.080). Conclusion Resection status was not identified as predictor of OS or DFS in PDAC patients with LN involvement. Extensive surgery to achieve R0 resection in such patients might not influence the disease course.
📖 Papers frequently viewed together
2019
8 Authors (Xiaodong Tian, ..., Yinmo Yang)
5 Authors (Bo Zhou, ..., Shusen Zheng)
7 Citations
1 Citations
References21
Newest
#1Kim C. Honselmann (Harvard University)H-Index: 10
#2Ilaria Pergolini (Harvard University)H-Index: 13
Last. Cristina R. FerroneH-Index: 77
view all 15 authors...
: MINI: Our study explores patterns of recurrence after potentially curative resection in lymph node-positive and lymph node-negative pancreatic cancer, including both timing and site of recurrence. Although the time to recurrence and median survival were significantly longer for pN0 as compared with pN1 cancer, there was no corresponding difference in site of first recurrence or metastasis in upfront resected patients, nor in neoadjuvant-treated patients. OBJECTIVE: Our aim was to evaluate recu...
14 CitationsSource
#1W. S. Tummers (LEI: Leiden University)H-Index: 1
#2Jesse V. Groen (LEI: Leiden University)H-Index: 5
Last. Rutger-Jan Swijnenburg (LEI: Leiden University)H-Index: 25
view all 11 authors...
Background: The prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) is poor and selection of patients for surgery is challenging. This study examined the impact of a positive resection margin (R1) on locoregional recurrence (LRR) and overall survival (OS); and also aimed to identified tumour characteristics and/or technical factors associated with a positive resection margin in patients with PDAC. Methods: Patients scheduled for pancreatic resection for PDAC between 2006 and 2016 ...
50 CitationsSource
#1Vincent P. Groot (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 16
#2Georgios Gemenetzis (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 17
Last. Jin HeH-Index: 40
view all 13 authors...
Objectives:To establish an evidence-based cut-off to differentiate between early and late recurrence and to compare clinicopathologic risk factors between the two groups.Summary Background Data:A clear definition of “early recurrence” after pancreatic ductal adenocarcinoma resection is currently lac
72 CitationsSource
Abstract Background Among patients with metastatic pancreatic cancer, combination chemotherapy with fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) leads to longer overall surviv...
612 CitationsSource
#1Jean Robert DelperoH-Index: 30
#2Florence JeuneH-Index: 1
Last. Jean Marie BoherH-Index: 11
view all 13 authors...
Objective:The aim of the study was to assess the relevance of resection margin status for survival after resection of pancreatic-head ductal adenocarcinoma.Summary Background Data:The definition and prognostic value of incomplete microscopic resection (R1) remain controversial.Methods:Prognostic fac
42 CitationsSource
#1Ihsan Ekin Demir (TUM: Technische Universität München)H-Index: 34
#2Carsten Jäger (TUM: Technische Universität München)H-Index: 11
Last. Güralp O. CeyhanH-Index: 41
view all 14 authors...
Objective: The aim of this study was to decipher the true importance of R0 versus R1 resection for survival in pancreatic ductal adenocarcinoma (PDAC). Summary of Background Data: PDAC is characterized by poor survival, even after curative resection. In many studies, R0 versus R1 does not result in different prognosis and does not affect the postoperative management. Methods: Pubmed, Embase, and Cochrane databases were screened for prognostic studies on the association between resection status a...
47 CitationsSource
#1Takeo Nitta (Hokkaido University)H-Index: 6
#2Toru Nakamura (Hokkaido University)H-Index: 16
Last. Satoshi Hirano (Hokkaido University)H-Index: 57
view all 14 authors...
Purpose The tumor-node-metastasis (TNM) classification defines R1 as the presence of tumor cells at the resection margin, while the current Royal College of Pathologists guidelines for pancreaticoduodenectomy specimens regard the presence of tumor cells within 1 mm from the resection margin as R1 (the “1-mm rule”). The aims of this study were to investigate the resection margin status of pancreatic head cancer retrospectively according to both the TNM and 1-mm rule classifications, and to evalua...
12 CitationsSource
#2Poorvi NarwadeH-Index: 1
Last. Marc G. BesselinkH-Index: 84
view all 10 authors...
Background Hepatic-artery and para-aortic lymph node metastases (LNM) may be detected during surgical exploration for pancreatic (PDAC) or periampullary cancer. Some surgeons will continue the resection while others abort the exploration.
16 CitationsSource
#1Thierry ConroyH-Index: 60
Last. Michel DucreuxH-Index: 8
view all 9 authors...
Pancreatic adenocarcinoma remains a devastating disease with a 5-year survival rate not exceeding 6%. Treatment of this disease remains a major challenge. This article reviews the state-of-the-art in the management of this disease and the new innovative approaches that may help to accelerate progress in treating its victims. After careful pre-therapeutic evaluation, only 15-20% of patients diagnosed with a pancreatic cancer (PC) are eligible for upfront radical surgery. After R0 or R1 resection ...
78 CitationsSource
#1Christina L. Roland (University of Texas MD Anderson Cancer Center)H-Index: 23
#2Anthony D. Yang (UC Davis: University of California, Davis)H-Index: 24
Last. Jason B. Fleming (University of Texas MD Anderson Cancer Center)H-Index: 69
view all 13 authors...
Background The use of neoadjuvant therapy (NAC) for the treatment of potentially resectable pancreatic cancer remains controversial. In this study, we sought to evaluate cancer-specific endpoints in patients undergoing a NAC versus a surgery-first (SF) approach with specific emphasis on lymph node metastases.
63 CitationsSource
Cited By0
Newest